Hong You

6.5k total citations · 2 hit papers
231 papers, 3.9k citations indexed

About

Hong You is a scholar working on Epidemiology, Hepatology and Molecular Biology. According to data from OpenAlex, Hong You has authored 231 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 140 papers in Epidemiology, 137 papers in Hepatology and 34 papers in Molecular Biology. Recurrent topics in Hong You's work include Liver Disease Diagnosis and Treatment (115 papers), Hepatitis B Virus Studies (74 papers) and Hepatitis C virus research (50 papers). Hong You is often cited by papers focused on Liver Disease Diagnosis and Treatment (115 papers), Hepatitis B Virus Studies (74 papers) and Hepatitis C virus research (50 papers). Hong You collaborates with scholars based in China, United States and Singapore. Hong You's co-authors include Jidong Jia, Aiting Yang, Min Cong, Tianhui Liu, Wei Chen, Yameng Sun, Paul L. Hermonat, Xiaojuan Ou, Yuanyuan Kong and Xinyan Zhao and has published in prestigious journals such as Circulation, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Hong You

213 papers receiving 3.8k citations

Hit Papers

Global liver disease burdens and research trends: Analysi... 2019 2026 2021 2023 2019 2023 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Global liver disease burdens and research trends: Analysis from a Chinese perspective
    2019 410 citations Hong You et al. Journal of Hepatology profile →
  2. Guidelines for the Prevention and Treatment of Chronic Hepatitis B (version 2022)
    2023 97 citations Hong You, Xiaoyuan Xu et al. Journal of Clinical and Translational Hepatology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hong You China 32 2.0k 1.7k 1.1k 610 408 231 3.9k
Ingmar Mederacke Germany 23 2.7k 1.3× 2.6k 1.5× 1.2k 1.1× 776 1.3× 564 1.4× 46 4.6k
Akio Ido Japan 38 1.7k 0.8× 1.6k 1.0× 1.0k 0.9× 929 1.5× 518 1.3× 243 4.4k
Pavel Strnad Germany 40 1.6k 0.8× 1.1k 0.6× 1.8k 1.6× 794 1.3× 449 1.1× 161 5.7k
Mitsuhiko Moriyama Japan 30 2.7k 1.4× 2.9k 1.7× 689 0.6× 549 0.9× 243 0.6× 221 4.9k
Kai Wang China 27 1.1k 0.5× 812 0.5× 980 0.9× 356 0.6× 569 1.4× 197 3.0k
Eckart Schott Germany 32 1.6k 0.8× 1.7k 1.0× 708 0.6× 457 0.7× 798 2.0× 69 3.6k
Iwata Ozaki Japan 32 1.3k 0.7× 838 0.5× 1.3k 1.1× 399 0.7× 213 0.5× 111 3.7k
Katharine M. Irvine Australia 36 1.3k 0.7× 873 0.5× 1.7k 1.5× 404 0.7× 1.3k 3.1× 116 4.4k
Marie‐Christine Saint‐Paul France 28 1.3k 0.6× 732 0.4× 736 0.7× 878 1.4× 293 0.7× 77 3.5k
Maria Lorena Abate Italy 31 3.2k 1.6× 3.1k 1.8× 688 0.6× 302 0.5× 400 1.0× 99 4.8k

Countries citing papers authored by Hong You

Since Specialization
Citations

This map shows the geographic impact of Hong You's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hong You with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hong You more than expected).

Fields of papers citing papers by Hong You

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hong You. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hong You. The network helps show where Hong You may publish in the future.

Co-authorship network of co-authors of Hong You

This figure shows the co-authorship network connecting the top 25 collaborators of Hong You. A scholar is included among the top collaborators of Hong You based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hong You. Hong You is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Hao, Xiaoqian Xu, Cheng Huang, et al.. (2025). Non-canonical Wnt signaling pathway activated NFATC3 promotes GDF15 expression in MASH: prospective analyses of UK biobank proteomic data. Hepatology International. 19(3). 662–672.
2.
3.
Zhao, Suxian, Jie Li, Lingdi Liu, et al.. (2025). Consensus on the Management of Liver Injury Associated with Targeted Drugs and Immune Checkpoint Inhibitors for Hepatocellular Carcinoma (Version 2024). Journal of Clinical and Translational Hepatology. 0(0). 0–0.
4.
You, Hong, et al.. (2025). High-precision copper-grade identification via a vision transformer with PGNAA. Nuclear Science and Techniques. 36(7). 1 indexed citations
5.
Zhao, Xinyu, Hongsen Chen, Jiayi Zhao, et al.. (2025). Prognostic and predictive effects of new steatotic liver disease nomenclatures: a large population‐based study. MedComm. 6(2). e70087–e70087. 3 indexed citations
6.
Liu, Feng, Yameng Sun, Dean Tai, et al.. (2024). AI Digital Pathology Using qFibrosis Shows Heterogeneity of Fibrosis Regression in Patients with Chronic Hepatitis B and C with Viral Response. Diagnostics. 14(16). 1837–1837. 2 indexed citations
7.
8.
Zhang, Ning, et al.. (2024). Atlas of mildly and highly insoluble matrisome driving liver fibrosis. Frontiers in Pharmacology. 15. 1435359–1435359. 2 indexed citations
9.
Zhang, Ning, Xiaoning Wu, Yameng Sun, et al.. (2024). Targeting thrombospondin-2 retards liver fibrosis by inhibiting TLR4-FAK/TGF-β signaling. JHEP Reports. 6(3). 101014–101014. 8 indexed citations
10.
Sun, Dan‐Qin, Jiaqi Shen, Yangyang Li, et al.. (2024). FRI-267 Regional fibrosis progression analysed by digital pathology with artificial intelligence is associated with renal dysfunction. Journal of Hepatology. 80. S488–S489. 1 indexed citations
11.
12.
You, Hong, Weijia Duan, Shuxiang Li, et al.. (2023). Guidelines on the Diagnosis and Management of Primary Biliary Cholangitis (2021). Journal of Clinical and Translational Hepatology. 0(0). 0–0. 13 indexed citations
13.
You, Hong, et al.. (2023). A Novel Metabolic Score for Predicting the Acute Exacerbation in Patients with Chronic Obstructive Pulmonary Disease. International Journal of COPD. Volume 18. 785–795. 11 indexed citations
14.
Chen, Wei, et al.. (2023). Pipeline for precise insoluble matrisome coverage in tissue extracellular matrices. Frontiers in Bioengineering and Biotechnology. 11. 1135936–1135936. 2 indexed citations
15.
Chen, Sha, Ting Lv, Shan Shan, et al.. (2023). Concomitant gallstone disease was not associated with long‐term outcomes in ursodeoxycholic acid‐treated patients with primary biliary cholangitis. Journal of Digestive Diseases. 24(6-7). 419–426. 1 indexed citations
16.
Han, Qi, Xuzhen Yan, Ning Zhang, et al.. (2023). Aryl hydrocarbon receptor attenuates cholestatic liver injury by regulating bile acid metabolism. Biochemical and Biophysical Research Communications. 682. 259–265. 2 indexed citations
17.
Chen, Wei, Yameng Sun, Shuyan Chen, et al.. (2023). Matrisome gene-based subclassification of patients with liver fibrosis identifies clinical and molecular heterogeneities. Hepatology. 78(4). 1118–1132. 15 indexed citations
18.
Yin, Rong, et al.. (2020). Knocking down PFL can improve myocardial ischemia/reperfusion injury in rats by up-regulating heat shock protein-20. SHILAP Revista de lepidopterología. 3 indexed citations
19.
Chen, Wei, Aiting Yang, Jidong Jia, et al.. (2020). Lysyl Oxidase (LOX) Family Members: Rationale and Their Potential as Therapeutic Targets for Liver Fibrosis. Hepatology. 72(2). 729–741. 181 indexed citations
20.
Zeng, Na, Zhiying He, Hong Ma, et al.. (2017). Systematic review on the reporting quality of randomized controlled trials in patients with hepatitis B or C in China. International Journal of Infectious Diseases. 67. 58–64. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ingmar Mederacke Breakdown of academic impact, for papers by Akio Ido Breakdown of academic impact, for papers by Pavel Strnad Breakdown of academic impact, for papers by Mitsuhiko Moriyama Breakdown of academic impact, for papers by Kai Wang Breakdown of academic impact, for papers by Eckart Schott Breakdown of academic impact, for papers by Iwata Ozaki Breakdown of academic impact, for papers by Katharine M. Irvine Breakdown of academic impact, for papers by Marie‐Christine Saint‐Paul Breakdown of academic impact, for papers by Maria Lorena Abate
Rankless by CCL
2026